Results 141 to 150 of about 110,488 (256)
Precision therapies for genetic epilepsies in 2025: Promises and pitfalls
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang +3 more
wiley +1 more source
Chronic sleep deprivation promotes drug‐resistant epilepsy via the BMAL1‐mTOR‐P‐gp axis
Abstract Objective The interplay between chronic sleep deprivation and drug‐resistant epilepsy (DRE) has gained increasing attention. Brain and muscle Arnt‐like protein 1 (BMAL1), which is implicated in sleep disturbance, has an unclear role in DRE. We aimed to investigate the role of BMAL1 in sleep deprivation‐induced DRE. Methods A pentylenetetrazole
Xiaomeng Wang +7 more
wiley +1 more source
An Expanded Toolbox for Versatile Chemical Editing of Adeno-Associated Virus. [PDF]
Pham Q +6 more
europepmc +1 more source
Engineering of High-Yield Recombinant Adeno-Associated Virus Producer Plasmids. [PDF]
Radukic MT +10 more
europepmc +1 more source
An Improved Method for Determining the Infection Titer of Replication-Competent Adeno-Associated Virus. [PDF]
Fu J +6 more
europepmc +1 more source
Characterization of adeno-associated virus binding to alginate and its controlled release. [PDF]
Amante JJ +4 more
europepmc +1 more source
What's New? This population‐based cohort study aimed to demonstrate how annual audits of all aspects of the cervical cancer screening pathway can be performed using register national data with clinical validation to identify patterns of risk and inform program change.
Cecilia Kärrberg +9 more
wiley +1 more source
Lyophilization of Adeno-Associated Virus Serotypes for Storage and Global Distribution. [PDF]
McGlinch EB +3 more
europepmc +1 more source
Clinical trials of chimeric antigen receptor T‐cell (CAR‐T) therapies in glioblastoma have shown limited clinical benefits. Whether this may be explained by the basal quality of CAR‐T products, which are currently generated using patient, autologous T‐cells, has been little explored.
Sabra K. Salim +22 more
wiley +1 more source
Adeno-Associated Virus Toxicity in Duchenne Muscular Dystrophy: Mechanisms and Clinical Considerations. [PDF]
Saylam E +3 more
europepmc +1 more source

